SMYD4单甲基化PRMT5并形成一个积极的反循环,促进肝细胞癌的进展
Zhenyu Zhou1,2, Zheng Chen3, Qianlei Zhou2,4
1Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Cancer science
|March 4, 2024
概括
氨基甲基转移酶SMYD4在肝细胞癌 (HCC) 中充当瘤基因. 针对SMYD4-PRMT5轴可能为HCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 氨酸和氨酸甲基转移酶被认为是癌症的治疗点.
- 这些酶在肝细胞癌 (HCC) 中的特定作用仍然不完全理解.
研究的目的:
- 研究氨基甲基转移酶SMYD4在HCC中的功能.
- 阐明SMYD4在HCC进展中的作用背后的分子机制.
- 探索SMYD4-PRMT5相互作用作为HCC的潜在治疗标.
主要方法:
- 在HCC组织中对SMYD4表达的定量分析.
- 在体外和体外实验评估SMYD4对HCC细胞增殖和转移的影响.
- 同免疫沉测试以确定SMYD4结合蛋白.
- 西方涂抹和qRT-PCR用于分析蛋白质和基因表达.
- 在体外和体内使用PRMT5抑制剂的治疗.
主要成果:
- 在HCC中,SMYD4被显著上调,促进瘤细胞的增殖和转移.
- SMYD4单甲基化PRMT5,增强其与MEP50的相互作用,导致特定的基因素修饰 (H3R2和H4R3).
- 这一过程导致关键基因 (DVL3,E-cadherin,RBL2,miR-29b-1-5p) 的表达发生改变,miR-29b-1-5p与SMYD4.4形成反循环.
- 抑制PRMT5有效抑制了SMYD4的致癌作用.
- 在HCC患者中,SMYD4和PRMT5的高联合表达与预后不佳相关.
结论:
- 通过与PRMT5.5的相互作用,SMYD4在HCC中作为瘤基因起作用.
- 在HCC中,SMYD4-PRMT5轴代表了氨酸和氨酸甲基转移酶之间的新型交叉声机制.
- 准SMYD4-PRMT5轴对HCC治疗具有前景.
更多相关视频
08:29SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
7.1K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
87
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
